Clinical trial Recruiting at 2 sites Interventional Ages 18 to 65

Tecar Therapy for Lumbar Radiculopathy

Official title: Efficacy of Tecar Therapy Versus Conventional Physical Therapy and Sham Treatment in Patients With Lumbar Radiculopathy: A Randomized Controlled Trial

Run by Izmir City Hospital · NCT07480252 · Data updated 2026-11-12

This trial tests whether Tecar therapy helps people with unilateral L5/S1 lumbar radiculopathy when added to standard physical therapy, compared with sham Tecar therapy and conventional therapy alone.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment90 (estimated)
SponsorIzmir City Hospital
Government
Locations2 sites (Izmir, İzmir and 1 other locations)
StatusRecruiting
StartedApril 15, 2026
Main results expectedApril 15, 2028
Study endsDecember 15, 2028
Registry record updatedOctober 14, 2026
Trial IDNCT07480252 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-65 with clinically diagnosed unilateral L5/S1 radiculopathy, symptom duration 6 weeks to 6 months, and radicular pain on VAS ≥3.

Probably not a fit

Patients with bilateral radiculopathy, canal stenosis on imaging, recent spine surgery, or contraindications to physical therapy or Tecar therapy may be less likely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This assessor-blinded, randomized trial will enroll 90 adults with unilateral L5 or S1 radiculopathy and symptoms lasting 6 weeks to 6 months at İzmir City Hospital. Participants are randomized to three groups: conventional physical therapy, Tecar therapy plus conventional therapy, or sham Tecar therapy plus conventional therapy. Tecar therapy uses capacitive and resistive energy transfer applied to the lower back and nearby muscles; the sham group mimics the procedure without energy output. All groups receive postural education and a home exercise program, with outcomes assessed by blinded evaluators. The study adheres to CONSORT guidance to ensure robust reporting.

Why it matters

Potential benefit: If successful, Tecar therapy could offer an additional non-invasive option to reduce pain and improve function for people with lumbar radiculopathy.

How similar studies have gone: Evidence for Tecar therapy in lumbar radiculopathy is limited, with this trial representing a relatively novel approach in this condition.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18-65 years
* Clinical diagnosis of unilateral L5 and/or S1 lumbar radiculopathy
* Symptom duration between 6 weeks and 6 months
* Average radicular pain intensity ≥3 on the Visual Analog Scale (VAS) during the previous month
* Availability of lumbar MRI and/or EMG performed within the previous 6 months
* Willingness to participate and ability to provide written informed consent

Exclusion Criteria:

* Bilateral lumbar radiculopathy
* Lumbar spinal canal stenosis confirmed by imaging or suspected clinically (e.g., neurogenic claudication)
* Lower limb muscle strength \<4/5 according to the Medical Research Council (MRC) scale
* Use of analgesic medications other than paracetamol during the study period
* Physical therapy treatment for low back or radicular pain within the past 3 months
* Contraindications to physical therapy modalities or Tecar therapy
* Previous lumbar spine surgery or interventional spinal procedures within the last 6 months
* Pregnancy, malignancy, or systemic neurological or rheumatologic disease
* Advanced spinal or lower extremity deformities (e.g., scoliosis \>20°, grade 3-4 spondylolisthesis, vertebral fracture, advanced coxarthrosis)
* Inability to complete the intervention protocol or follow-up assessments

Where it's running

  • İzmir City Hospital
    Izmir, İzmir, Turkey (Türkiye)
    Recruiting
  • İzmir Cİty Hospital
    Izmir, İzmir, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.